Patient(21) COVID-19(20) Chemotherapy(11) Treatment(11) therapy(11) Immunocompromised(10) lymphoma(9) rituximab(9) antibody(8) reported(8) review(7) risk(7) patients(7) Infection(7) receiving(7) SARS-CoV-2(7) prolonged disease(6) subsequent(6) Pneumonia(6) approach(6) outcome(6) Course(6) Immunosuppression(5) Complete(5) material(5) died(5) Multiple myeloma(5) COVID-19 infection(5) response(5) Mortality(5)